⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 25, 2015The Journal of Urology

Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate Cancer

Neal D. Shore Naveen Kella Brian J. Moran Judd Boczko Fernando J. Bianco E. David Crawford Thaylon Davis Kirstin M. Roundy Kristen Rushton Charles E. Grier Rajesh Kaldate Michael K. Brawer Mark L. Gonzalgo

View at Publisher

Ask AI

Bookmark

Share

Abstract

The cell cycle progression test has a significant impact in assisting physicians and patients reach personalized treatment decisions.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Shore et al. (2015) studied this question.

synapsesocial.com/papers/69dbdb1150e1971baba3d178 https://doi.org/10.1016/j.juro.2015.09.072

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Prostate specific antigen for early detection of prostate cancer: longitudinal studyCohort Study · 2009 · 133 citations
2Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per MilliliterOriginal Research · 2004 · 2,449 citations
3Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomycohort · 2006 · 144 citations
4Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005Original Research · 2009 · 575 citations
520-Year Outcomes Following Conservative Management of Clinically Localized Prostate CancerRetrospective Study · 2005 · 1,187 citations

More related papers

Mortality Results from a Randomized Prostate-Cancer Screening Trial2009
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer2005
Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer2010

More from The Journal of Urology

Anatomical Mapping of Lymphatic Leakage Leading to Symptomatic Lymphoceles Formation After Pelvic Lymph Node Dissection for Prostate CancerFri,
Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography / Magnetic Resonance Imaging in Selected Men with Equivocal Prostate Imaging Reporting and Data System Category 3 Lesion (PANDORA): A Prospective Paired Diagnostic StudyThu,